With three meds approved for weight management and several on the way, these may make a dent in the obesity epidemic.

The GLP-1 drugs are "truly causing a lot of disruption for the surgeons and for the programs, and for patients," Thomas Tsai, MD, a bariatric surgeon at Brigham and Women's Hospital in Boston, told ...

Over her three-decade career, weight management physician Dr. Sarah Ro has seen hundreds of patients. Many of them are on ...

On its way out the door, the Biden administration is proposing that Medicare and Medicaid cover Ozempic and other GLP-1 drugs ...

GLP-1 drugs such as Ozempic ... The department expects the cost of covering GLP-1s to be about $16 million a year under the new policy. By comparison, coverage for Dupixent, a drug commonly used to ...

Right now, Novo stock is trading at a forward price-to-earnings (P/E) multiple of 22.5 -- its lowest level in well over a ...

Industry leaders share their thoughts and concerns about the health care landscape and how it will affect their 2025.

Stay informed with Hindustan Times' live updates! Track the latest lifestyle news including fashion trends, style guide & ...

Technology often plays a critical role in strategies to combat rising costs while maintaining quality care. Here are four ...

It’s a decision that could potentially affect treatment options for millions — and cost tens of billions in ... Musk is also a member of the GLP-1 fan club. The industrialist tycoon, who ...

The small miracles that 2024 brought to our lives lay the groundwork for new revolutionary treatments that are being prepared ...